Leading BioSciences Receives IND Clearance for Phase 2 COVID-19 Study CARLSBAD, Calif., May 15, 2020 (GLOBE NEWSWIRE) -- Leading BioSciences, Inc. (LBS), a drug development company focused on improving human health through therapeutic protection of the intestinal...

Tiziana Lifesciences Develops Novel Investigational Treatment For Patients Infected with COVID-19 Utilizing Direct Delivery of Anti-Interlukin-6-Receptor Monoclonal Antibodies NEW YORK and LONDON, April 09, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for...